Events

Second Forum of the Mission adaptation to climate change
JUN
Tue
13
09:00 - 18:30

This was 2 years ago

Location

Online

Programmes
Climate, Energy, Mobility Missions

The European Commission is organising the Second Forum of the Mission adaptation to climate change.

The annual Forum will be the moment to take stock, identify issues, steer the Mission and define the path ahead.
 
This event was also organised last year. Recordings are available here
 
More details about registration will follow soon. 
 
The Mission Adaptation to Climate Change aims at supporting around 150 regions and communities in Europe towards reaching climate resilience by fostering the development of innovative solutions. Because climate change affects different regions, sectors of the economy and members of society in distinctive ways, the Mission will engage with the widest range of EU regional and local actors.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.